How should burning micturition (dysuria) be managed?

Management of Burning Micturition (Dysuria)

For women with acute dysuria and typical lower urinary tract symptoms (frequency, urgency) without vaginal discharge or complicating factors, first-line treatment is fosfomycin trometamol 3g single dose, nitrofurantoin 100mg twice daily for 5 days, or pivmecillinam 400mg three times daily for 3-5 days 1.

Initial Diagnostic Approach

Women with Uncomplicated Presentation

• Diagnosis can be made clinically based on acute-onset dysuria plus frequency/urgency without vaginal discharge 1
• Urine culture is not required for typical presentations in otherwise healthy women 1
• Dipstick testing adds minimal diagnostic accuracy but may be used if diagnosis is unclear 1

When Urine Culture IS Required

Obtain culture before treatment in these situations 1:

• Suspected pyelonephritis (fever, flank pain, costovertebral tenderness)
• Pregnancy
• Symptoms persisting or recurring within 4 weeks after treatment
• Atypical symptoms
• Men (all cases require 7-day treatment)

Elderly/Frail Patients

Different diagnostic criteria apply 2:

• Require recent onset dysuria PLUS systemic signs (fever >37.8°C, rigors, clear delirium) OR costovertebral angle tenderness
• Isolated dysuria, cloudy urine, or change in urine odor alone does not warrant antibiotics
• High prevalence of asymptomatic bacteriuria makes diagnosis challenging

Treatment Regimens

First-Line Options for Women (Uncomplicated Cystitis) 1

Antibiotic	Dose	Duration
Fosfomycin trometamol	3g single dose	1 day
Nitrofurantoin	100mg twice daily	5 days
Pivmecillinam	400mg three times daily	3-5 days

Alternative Options (if local E. coli resistance <20%) 1

• Cephalosporins (e.g., cefadroxil 500mg twice daily for 3 days)
• Trimethoprim 200mg twice daily for 5 days
• Trimethoprim-sulfamethoxazole 160/800mg twice daily for 3 days

Men with Dysuria 1

• Trimethoprim-sulfamethoxazole 160/800mg twice daily for 7 days
• Fluoroquinolones acceptable based on local susceptibility
• Longer duration needed as prostatitis cannot be excluded

Symptomatic Treatment Alternative

For women with mild-to-moderate symptoms, ibuprofen may be considered as an alternative to antibiotics after discussing risks/benefits 1. This approach:

• Reduces antibiotic exposure
• May be appropriate for patients prioritizing avoidance of antimicrobial side effects
• Requires patient understanding that symptoms may persist longer

Management of Treatment Failure

If symptoms persist at end of treatment or recur within 2 weeks 1:

1. Obtain urine culture with susceptibility testing
2. Assume organism is resistant to initial agent
3. Retreat with 7-day course using different antibiotic class
4. Do not perform routine post-treatment cultures in asymptomatic patients

Complicated UTI Considerations

Obtain culture and consider broader coverage if any of these factors present 1:

• Urinary tract obstruction or foreign body (catheter, stent)
• Male sex
• Pregnancy
• Diabetes mellitus
• Immunosuppression
• Recent instrumentation
• Healthcare-associated infection
• History of multidrug-resistant organisms

For complicated UTI with systemic symptoms, empiric treatment includes 1:

• Amoxicillin plus aminoglycoside, OR
• Second-generation cephalosporin plus aminoglycoside, OR
• Intravenous third-generation cephalosporin

Critical Pitfalls to Avoid

1. Do not treat asymptomatic bacteriuria in non-pregnant women—this increases resistance and recurrence risk 3
2. Do not use nitrofurantoin, fosfomycin, or pivmecillinam for pyelonephritis—insufficient tissue penetration 1
3. In elderly patients, do not diagnose UTI based solely on positive urine culture or cloudy/malodorous urine without acute localized symptoms 2
4. Avoid fluoroquinolones for empiric treatment if local resistance >10% or recent fluoroquinolone use within 6 months 1
5. Do not perform extensive workup (cystoscopy, imaging) in women <40 years with recurrent UTI and no risk factors 1

Recurrent Dysuria/UTI Prevention

If ≥2 episodes in 6 months or ≥3 in 12 months 1:

Stepwise approach:

1. Behavioral modifications first: increase fluid intake, address modifiable risk factors
2. Postmenopausal women: vaginal estrogen (strong recommendation) 1
3. Non-antimicrobial options:
   • Methenamine hippurate (strong recommendation) 1
   • Immunoactive prophylaxis (OM-89) 1
   • Cranberry products (weak evidence) 1
4. Antimicrobial prophylaxis only after non-antimicrobial measures fail: continuous low-dose or post-coital antibiotics 1

The evidence strongly supports exhausting non-antimicrobial strategies before resorting to antibiotic prophylaxis to minimize resistance development and adverse effects.